Home › Funds › HEIGHTS CAPITAL MANAGEMENT, INC › TSHA
HEIGHTS CAPITAL MANAGEMENT, INC position in TSHA
TAYSHA GENE THERAPIES INC · Health Care
HEIGHTS CAPITAL MANAGEMENT, INC reported holding 1,500,000 shares of TSHA (TAYSHA GENE THERAPIES INC) in its Q2 2026 13F filing — a position valued at US$10.2M, representing 2.36% of its reported portfolio and ranking #4 among its reported holdings. HEIGHTS CAPITAL MANAGEMENT, INC first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How HEIGHTS CAPITAL MANAGEMENT, INC's TSHA position evolved
HEIGHTS CAPITAL MANAGEMENT, INC first disclosed a stake in TSHA in Q2 2026 at 1,500,000 shares (US$10.2M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 1.50M | $10.21M | New |
About TSHA and 13F data
TSHA (TAYSHA GENE THERAPIES INC) is a Health Care company. 56 other funds we track also report a position in TSHA — the largest reported positions include Avoro Capital Advisors LLC (US$162.7M), RA CAPITAL MANAGEMENT, L.P. (US$160.4M), Vestal Point Capital, LP (US$132.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TSHA
- Avoro Capital Advisors LLC 23.89M sh · $162.68M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 23.56M sh · $160.41M · Q2 2026
- Vestal Point Capital, LP 19.41M sh · $132.22M · Q2 2026
- RTW INVESTMENTS, LP 13.56M sh · $92.35M · Q2 2026
- Siren, L.L.C. 9.85M sh · $67.06M · Q2 2026
- Octagon Capital Advisors LP 9.69M sh · $66.01M · Q2 2026
- MPM BioImpact LLC 4.50M sh · $30.64M · Q2 2026
- BAKER BROS. ADVISORS LP 4.00M sh · $27.27M · Q2 2026
- GordonMD Global Investments LP 723.18K sh · $24.50M · Q2 2026
- Casdin Capital 3.25M sh · $22.13M · Q2 2026
- ADAR1 Capital Management, LLC 3.04M sh · $20.71M · Q2 2026
- RICE HALL JAMES & ASSOCIATES, LLC 1.99M sh · $13.57M · Q2 2026
More on HEIGHTS CAPITAL MANAGEMENT, INC
FAQ
How long has HEIGHTS CAPITAL MANAGEMENT, INC held TSHA?
HEIGHTS CAPITAL MANAGEMENT, INC has disclosed TSHA holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is HEIGHTS CAPITAL MANAGEMENT, INC's current position in TSHA?
As of Q2 2026, HEIGHTS CAPITAL MANAGEMENT, INC holds 1.50M shares of TSHA (TAYSHA GENE THERAPIES INC), valued at $10.21M, representing 2.36% of its reported portfolio and ranking #4.
Has HEIGHTS CAPITAL MANAGEMENT, INC been buying or selling TSHA?
In the latest 13F filing (Q2 2026), HEIGHTS CAPITAL MANAGEMENT, INC newly opened its position in TSHA.
Which other funds hold TSHA?
Other major institutional holders of TSHA include Avoro Capital Advisors LLC, RA CAPITAL MANAGEMENT, L.P., Vestal Point Capital, LP, among 56 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.